European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

RSS icon
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

Polypill strategy improves odds of survival after a heart attack

The new findings, presented during ESC Congress 2022 and published in the New England Journal of Medicine, suggest that prescribing these new-look pills to heart patients could boost outcomes while also improving medication adherence.

Thumbnail

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

Thumbnail

Medical marijuana linked to a higher risk of heart rhythm issues

The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. 

AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.

VIDEO: Why plaque composition CT imaging may be the future of cardiology

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 

Transcatheter aortic valve replacement (TAVR) patients continue to benefit from an optimized pre- and post-procedural treatment strategy that utilizes the cusp overlap technique, according to new findings presented at EuroPCR 2022 in Paris.

Cusp overlap technique, optimized treatment strategy tied to significant improvements for TAVR patients

The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.

Thumbnail

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

Thumbnail

European Society of Cardiology publishes new genetic testing guidelines for heart conditions

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

Women less likely to receive treatment, more likely to die after cardiogenic shock

Emerging data about differences in treatment for women and men may shed light on diverging outcomes.

Displaying 49 - 56 of 87

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup